Deka Bank Deutsche Girozentrale Kodiak Sciences Inc. Transaction History

Deka Bank Deutsche Girozentrale

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$5.04 - $9.48 $27,266 - $51,286	-5,410 Closed	0 $0
Q1 2022 Apr 28, 2022	BUY	$7.09 - $89.45 $3,545 - $44,725	500 Added 10.18%	5,410 $42,000
Q4 2021 Feb 02, 2022	BUY	$80.85 - $128.49 $12,127 - $19,273	150 Added 3.15%	4,910 $426,000
Q4 2020 Mar 12, 2021	BUY	$60.78 - $154.03 $289,312 - $733,182	4,760 New	4,760 $691,000

39M

6.5K

5.8K

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $341M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.